Wyeth, Schwarz Escape Reglan Failure-To-Warn Suit

Law360, New York (April 30, 2010, 2:28 PM EDT) -- In a ruling in line with recent federal appeals court decisions, a district judge has held that Wyeth Inc. and Schwarz Pharma Inc., makers of brand-name gastric reflux drug Reglan, cannot be held liable for the failure of its generic rivals to include warnings that the product could cause a neurological disorder.

The summary judgment ruling issued by Judge Marcia A. Crone of the U.S. District Court for the Eastern District of Texas on Wednesday said state law and federal precedent in recent appeals court rulings...
To view the full article, register now.




Case Information

Case Title

Finnicum v. Wyeth, Inc. et al

Case Number



Texas Eastern

Nature of Suit

Personal Inj. Prod. Liability


Marcia A. Crone

Date Filed

August 14, 2009

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.